nodes	percent_of_prediction	percent_of_DWPC	metapath
Sildenafil—ABCC5—Fluorouracil—colon cancer	0.168	0.217	CbGbCtD
Sildenafil—ABCC10—Vincristine—colon cancer	0.153	0.198	CbGbCtD
Sildenafil—ABCC10—Methotrexate—colon cancer	0.0927	0.12	CbGbCtD
Sildenafil—ABCC4—Fluorouracil—colon cancer	0.0808	0.104	CbGbCtD
Sildenafil—ABCC4—Methotrexate—colon cancer	0.0445	0.0576	CbGbCtD
Sildenafil—CYP3A7-CYP3A51P—Irinotecan—colon cancer	0.0334	0.0432	CbGbCtD
Sildenafil—CYP3A7—Irinotecan—colon cancer	0.0334	0.0432	CbGbCtD
Sildenafil—CYP3A7-CYP3A51P—Vincristine—colon cancer	0.0292	0.0378	CbGbCtD
Sildenafil—CYP3A7—Vincristine—colon cancer	0.0292	0.0378	CbGbCtD
Sildenafil—CYP2C9—Capecitabine—colon cancer	0.0272	0.0352	CbGbCtD
Sildenafil—CYP3A5—Irinotecan—colon cancer	0.0251	0.0324	CbGbCtD
Sildenafil—CYP3A5—Vincristine—colon cancer	0.0219	0.0283	CbGbCtD
Sildenafil—CYP2C9—Fluorouracil—colon cancer	0.0161	0.0209	CbGbCtD
Sildenafil—CYP3A4—Irinotecan—colon cancer	0.00978	0.0126	CbGbCtD
Sildenafil—CYP3A4—Vincristine—colon cancer	0.00855	0.0111	CbGbCtD
Sildenafil—PDE5A—endothelium—colon cancer	0.00317	0.0755	CbGeAlD
Sildenafil—PDE5A—blood vessel—colon cancer	0.00292	0.0696	CbGeAlD
Sildenafil—PDE6G—liver—colon cancer	0.00204	0.0486	CbGeAlD
Sildenafil—PDE6G—lymph node—colon cancer	0.00156	0.0372	CbGeAlD
Sildenafil—PDE5A—epithelium—colon cancer	0.00142	0.0339	CbGeAlD
Sildenafil—PDE5A—smooth muscle tissue—colon cancer	0.00137	0.0326	CbGeAlD
Sildenafil—PDE5A—renal system—colon cancer	0.00132	0.0314	CbGeAlD
Sildenafil—ADORA2A—lymphoid tissue—colon cancer	0.0012	0.0286	CbGeAlD
Sildenafil—PDE5A—digestive system—colon cancer	0.00108	0.0258	CbGeAlD
Sildenafil—ABCC10—renal system—colon cancer	0.00101	0.024	CbGeAlD
Sildenafil—PDE5A—vagina—colon cancer	0.000956	0.0228	CbGeAlD
Sildenafil—CYP3A7—liver—colon cancer	0.000952	0.0227	CbGeAlD
Sildenafil—ABCC5—bone marrow—colon cancer	0.000913	0.0217	CbGeAlD
Sildenafil—ADORA2A—liver—colon cancer	0.000886	0.0211	CbGeAlD
Sildenafil—ABCC5—vagina—colon cancer	0.000875	0.0208	CbGeAlD
Sildenafil—ABCC10—lymphoid tissue—colon cancer	0.000838	0.0199	CbGeAlD
Sildenafil—ABCC4—renal system—colon cancer	0.000837	0.0199	CbGeAlD
Sildenafil—ABCC10—digestive system—colon cancer	0.000828	0.0197	CbGeAlD
Sildenafil—CYP3A7-CYP3A51P—liver—colon cancer	0.00081	0.0193	CbGeAlD
Sildenafil—ABCC10—bone marrow—colon cancer	0.000763	0.0182	CbGeAlD
Sildenafil—ABCC5—liver—colon cancer	0.000738	0.0176	CbGeAlD
Sildenafil—ABCC10—vagina—colon cancer	0.000731	0.0174	CbGeAlD
Sildenafil—ABCC4—digestive system—colon cancer	0.000686	0.0163	CbGeAlD
Sildenafil—ABCC4—bone marrow—colon cancer	0.000633	0.0151	CbGeAlD
Sildenafil—PDE5A—lymph node—colon cancer	0.000619	0.0147	CbGeAlD
Sildenafil—ABCC10—liver—colon cancer	0.000617	0.0147	CbGeAlD
Sildenafil—CYP1A1—epithelium—colon cancer	0.000605	0.0144	CbGeAlD
Sildenafil—CYP2C19—digestive system—colon cancer	0.000571	0.0136	CbGeAlD
Sildenafil—ABCC5—lymph node—colon cancer	0.000566	0.0135	CbGeAlD
Sildenafil—CYP1A1—renal system—colon cancer	0.000561	0.0133	CbGeAlD
Sildenafil—CYP3A5—renal system—colon cancer	0.000548	0.0131	CbGeAlD
Sildenafil—CYP2E1—renal system—colon cancer	0.000512	0.0122	CbGeAlD
Sildenafil—ABCC4—liver—colon cancer	0.000511	0.0122	CbGeAlD
Sildenafil—CYP2C19—vagina—colon cancer	0.000504	0.012	CbGeAlD
Sildenafil—ABCC10—lymph node—colon cancer	0.000473	0.0112	CbGeAlD
Sildenafil—CYP1A1—digestive system—colon cancer	0.00046	0.0109	CbGeAlD
Sildenafil—CYP3A5—digestive system—colon cancer	0.00045	0.0107	CbGeAlD
Sildenafil—CYP2C9—digestive system—colon cancer	0.000443	0.0105	CbGeAlD
Sildenafil—CYP2C19—liver—colon cancer	0.000425	0.0101	CbGeAlD
Sildenafil—CYP2E1—lymphoid tissue—colon cancer	0.000425	0.0101	CbGeAlD
Sildenafil—CYP2E1—digestive system—colon cancer	0.00042	0.00998	CbGeAlD
Sildenafil—CYP3A4—renal system—colon cancer	0.000412	0.00979	CbGeAlD
Sildenafil—CYP1A1—vagina—colon cancer	0.000406	0.00967	CbGeAlD
Sildenafil—CYP2D6—renal system—colon cancer	0.000405	0.00964	CbGeAlD
Sildenafil—CYP3A5—vagina—colon cancer	0.000397	0.00945	CbGeAlD
Sildenafil—ABCC4—lymph node—colon cancer	0.000392	0.00933	CbGeAlD
Sildenafil—CYP1A1—liver—colon cancer	0.000343	0.00816	CbGeAlD
Sildenafil—CYP3A4—digestive system—colon cancer	0.000338	0.00803	CbGeAlD
Sildenafil—CYP3A5—liver—colon cancer	0.000335	0.00797	CbGeAlD
Sildenafil—CYP2D6—digestive system—colon cancer	0.000332	0.00791	CbGeAlD
Sildenafil—CYP2C9—liver—colon cancer	0.00033	0.00785	CbGeAlD
Sildenafil—CYP2E1—liver—colon cancer	0.000313	0.00744	CbGeAlD
Sildenafil—CYP1A1—lymph node—colon cancer	0.000263	0.00625	CbGeAlD
Sildenafil—CYP3A4—liver—colon cancer	0.000251	0.00598	CbGeAlD
Sildenafil—CYP2D6—liver—colon cancer	0.000247	0.00589	CbGeAlD
Sildenafil—Convulsion—Fluorouracil—colon cancer	0.000238	0.00135	CcSEcCtD
Sildenafil—Osteoarthritis—Methotrexate—colon cancer	0.000237	0.00134	CcSEcCtD
Sildenafil—Nervous system disorder—Vincristine—colon cancer	0.000235	0.00133	CcSEcCtD
Sildenafil—Haematuria—Capecitabine—colon cancer	0.000234	0.00133	CcSEcCtD
Sildenafil—Oedema—Irinotecan—colon cancer	0.000234	0.00133	CcSEcCtD
Sildenafil—Chest pain—Fluorouracil—colon cancer	0.000233	0.00132	CcSEcCtD
Sildenafil—Myalgia—Fluorouracil—colon cancer	0.000233	0.00132	CcSEcCtD
Sildenafil—Infection—Irinotecan—colon cancer	0.000232	0.00132	CcSEcCtD
Sildenafil—Hyperhidrosis—Vincristine—colon cancer	0.000232	0.00132	CcSEcCtD
Sildenafil—Epistaxis—Capecitabine—colon cancer	0.000231	0.00131	CcSEcCtD
Sildenafil—Discomfort—Fluorouracil—colon cancer	0.000231	0.00131	CcSEcCtD
Sildenafil—Shock—Irinotecan—colon cancer	0.00023	0.0013	CcSEcCtD
Sildenafil—Nervous system disorder—Irinotecan—colon cancer	0.000229	0.0013	CcSEcCtD
Sildenafil—Anorexia—Vincristine—colon cancer	0.000229	0.0013	CcSEcCtD
Sildenafil—Irritability—Methotrexate—colon cancer	0.000226	0.00128	CcSEcCtD
Sildenafil—Hyperhidrosis—Irinotecan—colon cancer	0.000226	0.00128	CcSEcCtD
Sildenafil—Hypotension—Vincristine—colon cancer	0.000224	0.00127	CcSEcCtD
Sildenafil—Oedema—Fluorouracil—colon cancer	0.000224	0.00127	CcSEcCtD
Sildenafil—Anorexia—Irinotecan—colon cancer	0.000223	0.00126	CcSEcCtD
Sildenafil—Ataxia—Methotrexate—colon cancer	0.000223	0.00126	CcSEcCtD
Sildenafil—Infection—Fluorouracil—colon cancer	0.000222	0.00126	CcSEcCtD
Sildenafil—Haemoglobin—Capecitabine—colon cancer	0.000221	0.00125	CcSEcCtD
Sildenafil—Rhinitis—Capecitabine—colon cancer	0.000221	0.00125	CcSEcCtD
Sildenafil—Haemorrhage—Capecitabine—colon cancer	0.00022	0.00125	CcSEcCtD
Sildenafil—Nervous system disorder—Fluorouracil—colon cancer	0.000219	0.00124	CcSEcCtD
Sildenafil—Hypoaesthesia—Capecitabine—colon cancer	0.000219	0.00124	CcSEcCtD
Sildenafil—Liver function test abnormal—Methotrexate—colon cancer	0.000219	0.00124	CcSEcCtD
Sildenafil—Musculoskeletal discomfort—Vincristine—colon cancer	0.000219	0.00124	CcSEcCtD
Sildenafil—Pharyngitis—Capecitabine—colon cancer	0.000218	0.00124	CcSEcCtD
Sildenafil—Tachycardia—Fluorouracil—colon cancer	0.000218	0.00124	CcSEcCtD
Sildenafil—Hypotension—Irinotecan—colon cancer	0.000218	0.00124	CcSEcCtD
Sildenafil—Urinary tract disorder—Capecitabine—colon cancer	0.000217	0.00123	CcSEcCtD
Sildenafil—Insomnia—Vincristine—colon cancer	0.000217	0.00123	CcSEcCtD
Sildenafil—Oedema peripheral—Capecitabine—colon cancer	0.000217	0.00123	CcSEcCtD
Sildenafil—Connective tissue disorder—Capecitabine—colon cancer	0.000216	0.00123	CcSEcCtD
Sildenafil—Urethral disorder—Capecitabine—colon cancer	0.000216	0.00122	CcSEcCtD
Sildenafil—Paraesthesia—Vincristine—colon cancer	0.000215	0.00122	CcSEcCtD
Sildenafil—Breast disorder—Methotrexate—colon cancer	0.000214	0.00121	CcSEcCtD
Sildenafil—Anorexia—Fluorouracil—colon cancer	0.000213	0.00121	CcSEcCtD
Sildenafil—Toxic epidermal necrolysis—Methotrexate—colon cancer	0.000213	0.00121	CcSEcCtD
Sildenafil—Visual impairment—Capecitabine—colon cancer	0.000212	0.0012	CcSEcCtD
Sildenafil—Insomnia—Irinotecan—colon cancer	0.000211	0.0012	CcSEcCtD
Sildenafil—Paraesthesia—Irinotecan—colon cancer	0.00021	0.00119	CcSEcCtD
Sildenafil—Hypotension—Fluorouracil—colon cancer	0.000209	0.00119	CcSEcCtD
Sildenafil—Decreased appetite—Vincristine—colon cancer	0.000209	0.00118	CcSEcCtD
Sildenafil—Dyspnoea—Irinotecan—colon cancer	0.000208	0.00118	CcSEcCtD
Sildenafil—Erythema multiforme—Capecitabine—colon cancer	0.000208	0.00118	CcSEcCtD
Sildenafil—Somnolence—Irinotecan—colon cancer	0.000208	0.00118	CcSEcCtD
Sildenafil—Gastrointestinal disorder—Vincristine—colon cancer	0.000207	0.00117	CcSEcCtD
Sildenafil—Fatigue—Vincristine—colon cancer	0.000207	0.00117	CcSEcCtD
Sildenafil—Eye disorder—Capecitabine—colon cancer	0.000206	0.00117	CcSEcCtD
Sildenafil—Dyspepsia—Irinotecan—colon cancer	0.000206	0.00117	CcSEcCtD
Sildenafil—Tinnitus—Capecitabine—colon cancer	0.000205	0.00116	CcSEcCtD
Sildenafil—Constipation—Vincristine—colon cancer	0.000205	0.00116	CcSEcCtD
Sildenafil—Pain—Vincristine—colon cancer	0.000205	0.00116	CcSEcCtD
Sildenafil—Asthma—Methotrexate—colon cancer	0.000205	0.00116	CcSEcCtD
Sildenafil—Flushing—Capecitabine—colon cancer	0.000204	0.00116	CcSEcCtD
Sildenafil—Cardiac disorder—Capecitabine—colon cancer	0.000204	0.00116	CcSEcCtD
Sildenafil—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000204	0.00116	CcSEcCtD
Sildenafil—Decreased appetite—Irinotecan—colon cancer	0.000203	0.00115	CcSEcCtD
Sildenafil—Insomnia—Fluorouracil—colon cancer	0.000202	0.00115	CcSEcCtD
Sildenafil—Gastrointestinal disorder—Irinotecan—colon cancer	0.000202	0.00114	CcSEcCtD
Sildenafil—Fatigue—Irinotecan—colon cancer	0.000201	0.00114	CcSEcCtD
Sildenafil—Paraesthesia—Fluorouracil—colon cancer	0.000201	0.00114	CcSEcCtD
Sildenafil—Pain—Irinotecan—colon cancer	0.0002	0.00113	CcSEcCtD
Sildenafil—Constipation—Irinotecan—colon cancer	0.0002	0.00113	CcSEcCtD
Sildenafil—Angiopathy—Capecitabine—colon cancer	0.0002	0.00113	CcSEcCtD
Sildenafil—Dyspnoea—Fluorouracil—colon cancer	0.000199	0.00113	CcSEcCtD
Sildenafil—Somnolence—Fluorouracil—colon cancer	0.000199	0.00113	CcSEcCtD
Sildenafil—Immune system disorder—Capecitabine—colon cancer	0.000199	0.00113	CcSEcCtD
Sildenafil—Mediastinal disorder—Capecitabine—colon cancer	0.000198	0.00113	CcSEcCtD
Sildenafil—Chills—Capecitabine—colon cancer	0.000197	0.00112	CcSEcCtD
Sildenafil—Dyspepsia—Fluorouracil—colon cancer	0.000197	0.00112	CcSEcCtD
Sildenafil—Arrhythmia—Capecitabine—colon cancer	0.000197	0.00112	CcSEcCtD
Sildenafil—Gastrointestinal pain—Vincristine—colon cancer	0.000196	0.00111	CcSEcCtD
Sildenafil—Decreased appetite—Fluorouracil—colon cancer	0.000194	0.0011	CcSEcCtD
Sildenafil—Alopecia—Capecitabine—colon cancer	0.000194	0.0011	CcSEcCtD
Sildenafil—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000193	0.0011	CcSEcCtD
Sildenafil—Mental disorder—Capecitabine—colon cancer	0.000193	0.00109	CcSEcCtD
Sildenafil—Feeling abnormal—Irinotecan—colon cancer	0.000193	0.00109	CcSEcCtD
Sildenafil—Erythema—Capecitabine—colon cancer	0.000192	0.00109	CcSEcCtD
Sildenafil—Malnutrition—Capecitabine—colon cancer	0.000192	0.00109	CcSEcCtD
Sildenafil—Pain—Fluorouracil—colon cancer	0.000191	0.00109	CcSEcCtD
Sildenafil—Gastrointestinal pain—Irinotecan—colon cancer	0.000191	0.00108	CcSEcCtD
Sildenafil—Upper respiratory tract infection—Methotrexate—colon cancer	0.00019	0.00108	CcSEcCtD
Sildenafil—Abdominal pain—Vincristine—colon cancer	0.00019	0.00108	CcSEcCtD
Sildenafil—Body temperature increased—Vincristine—colon cancer	0.00019	0.00108	CcSEcCtD
Sildenafil—Flatulence—Capecitabine—colon cancer	0.000189	0.00107	CcSEcCtD
Sildenafil—Erectile dysfunction—Methotrexate—colon cancer	0.000189	0.00107	CcSEcCtD
Sildenafil—Photosensitivity reaction—Methotrexate—colon cancer	0.000187	0.00106	CcSEcCtD
Sildenafil—Back pain—Capecitabine—colon cancer	0.000185	0.00105	CcSEcCtD
Sildenafil—Body temperature increased—Irinotecan—colon cancer	0.000185	0.00105	CcSEcCtD
Sildenafil—Abdominal pain—Irinotecan—colon cancer	0.000185	0.00105	CcSEcCtD
Sildenafil—Feeling abnormal—Fluorouracil—colon cancer	0.000184	0.00105	CcSEcCtD
Sildenafil—Pneumonia—Methotrexate—colon cancer	0.000184	0.00104	CcSEcCtD
Sildenafil—Infestation NOS—Methotrexate—colon cancer	0.000182	0.00104	CcSEcCtD
Sildenafil—Infestation—Methotrexate—colon cancer	0.000182	0.00104	CcSEcCtD
Sildenafil—Depression—Methotrexate—colon cancer	0.000182	0.00103	CcSEcCtD
Sildenafil—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.000181	0.00103	CcSEcCtD
Sildenafil—Vision blurred—Capecitabine—colon cancer	0.000181	0.00102	CcSEcCtD
Sildenafil—Tremor—Capecitabine—colon cancer	0.000179	0.00102	CcSEcCtD
Sildenafil—Renal failure—Methotrexate—colon cancer	0.000179	0.00102	CcSEcCtD
Sildenafil—Stomatitis—Methotrexate—colon cancer	0.000178	0.00101	CcSEcCtD
Sildenafil—Ill-defined disorder—Capecitabine—colon cancer	0.000178	0.00101	CcSEcCtD
Sildenafil—Urticaria—Fluorouracil—colon cancer	0.000178	0.00101	CcSEcCtD
Sildenafil—Conjunctivitis—Methotrexate—colon cancer	0.000177	0.00101	CcSEcCtD
Sildenafil—Anaemia—Capecitabine—colon cancer	0.000177	0.001	CcSEcCtD
Sildenafil—Body temperature increased—Fluorouracil—colon cancer	0.000177	0.001	CcSEcCtD
Sildenafil—Hypersensitivity—Vincristine—colon cancer	0.000177	0.001	CcSEcCtD
Sildenafil—Sweating—Methotrexate—colon cancer	0.000175	0.000992	CcSEcCtD
Sildenafil—Haematuria—Methotrexate—colon cancer	0.000174	0.000987	CcSEcCtD
Sildenafil—Malaise—Capecitabine—colon cancer	0.000173	0.00098	CcSEcCtD
Sildenafil—Epistaxis—Methotrexate—colon cancer	0.000172	0.000976	CcSEcCtD
Sildenafil—Vertigo—Capecitabine—colon cancer	0.000172	0.000976	CcSEcCtD
Sildenafil—Hypersensitivity—Irinotecan—colon cancer	0.000172	0.000976	CcSEcCtD
Sildenafil—Asthenia—Vincristine—colon cancer	0.000172	0.000976	CcSEcCtD
Sildenafil—Syncope—Capecitabine—colon cancer	0.000172	0.000974	CcSEcCtD
Sildenafil—Leukopenia—Capecitabine—colon cancer	0.000171	0.000973	CcSEcCtD
Sildenafil—Palpitations—Capecitabine—colon cancer	0.000169	0.00096	CcSEcCtD
Sildenafil—Loss of consciousness—Capecitabine—colon cancer	0.000168	0.000955	CcSEcCtD
Sildenafil—Asthenia—Irinotecan—colon cancer	0.000168	0.000951	CcSEcCtD
Sildenafil—Cough—Capecitabine—colon cancer	0.000167	0.000948	CcSEcCtD
Sildenafil—Hypertension—Capecitabine—colon cancer	0.000165	0.000938	CcSEcCtD
Sildenafil—Hypersensitivity—Fluorouracil—colon cancer	0.000165	0.000935	CcSEcCtD
Sildenafil—Haemoglobin—Methotrexate—colon cancer	0.000165	0.000934	CcSEcCtD
Sildenafil—Diarrhoea—Vincristine—colon cancer	0.000164	0.000931	CcSEcCtD
Sildenafil—Haemorrhage—Methotrexate—colon cancer	0.000164	0.000929	CcSEcCtD
Sildenafil—Arthralgia—Capecitabine—colon cancer	0.000163	0.000925	CcSEcCtD
Sildenafil—Chest pain—Capecitabine—colon cancer	0.000163	0.000925	CcSEcCtD
Sildenafil—Myalgia—Capecitabine—colon cancer	0.000163	0.000925	CcSEcCtD
Sildenafil—Pharyngitis—Methotrexate—colon cancer	0.000163	0.000922	CcSEcCtD
Sildenafil—Anxiety—Capecitabine—colon cancer	0.000163	0.000922	CcSEcCtD
Sildenafil—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000162	0.000919	CcSEcCtD
Sildenafil—Urinary tract disorder—Methotrexate—colon cancer	0.000162	0.000918	CcSEcCtD
Sildenafil—Discomfort—Capecitabine—colon cancer	0.000161	0.000914	CcSEcCtD
Sildenafil—Urethral disorder—Methotrexate—colon cancer	0.000161	0.000911	CcSEcCtD
Sildenafil—Diarrhoea—Irinotecan—colon cancer	0.00016	0.000907	CcSEcCtD
Sildenafil—Dry mouth—Capecitabine—colon cancer	0.00016	0.000905	CcSEcCtD
Sildenafil—Dizziness—Vincristine—colon cancer	0.000159	0.0009	CcSEcCtD
Sildenafil—Pruritus—Fluorouracil—colon cancer	0.000158	0.000898	CcSEcCtD
Sildenafil—Visual impairment—Methotrexate—colon cancer	0.000158	0.000896	CcSEcCtD
Sildenafil—Oedema—Capecitabine—colon cancer	0.000156	0.000887	CcSEcCtD
Sildenafil—Infection—Capecitabine—colon cancer	0.000155	0.000881	CcSEcCtD
Sildenafil—Erythema multiforme—Methotrexate—colon cancer	0.000155	0.000879	CcSEcCtD
Sildenafil—Dizziness—Irinotecan—colon cancer	0.000154	0.000876	CcSEcCtD
Sildenafil—Shock—Capecitabine—colon cancer	0.000154	0.000873	CcSEcCtD
Sildenafil—Nervous system disorder—Capecitabine—colon cancer	0.000153	0.00087	CcSEcCtD
Sildenafil—Eye disorder—Methotrexate—colon cancer	0.000153	0.000868	CcSEcCtD
Sildenafil—Diarrhoea—Fluorouracil—colon cancer	0.000153	0.000868	CcSEcCtD
Sildenafil—Tinnitus—Methotrexate—colon cancer	0.000153	0.000866	CcSEcCtD
Sildenafil—Tachycardia—Capecitabine—colon cancer	0.000153	0.000866	CcSEcCtD
Sildenafil—Vomiting—Vincristine—colon cancer	0.000153	0.000865	CcSEcCtD
Sildenafil—Cardiac disorder—Methotrexate—colon cancer	0.000152	0.000862	CcSEcCtD
Sildenafil—Skin disorder—Capecitabine—colon cancer	0.000152	0.000861	CcSEcCtD
Sildenafil—Rash—Vincristine—colon cancer	0.000151	0.000858	CcSEcCtD
Sildenafil—Hyperhidrosis—Capecitabine—colon cancer	0.000151	0.000857	CcSEcCtD
Sildenafil—Dermatitis—Vincristine—colon cancer	0.000151	0.000857	CcSEcCtD
Sildenafil—Headache—Vincristine—colon cancer	0.00015	0.000852	CcSEcCtD
Sildenafil—Anorexia—Capecitabine—colon cancer	0.000149	0.000845	CcSEcCtD
Sildenafil—Angiopathy—Methotrexate—colon cancer	0.000149	0.000843	CcSEcCtD
Sildenafil—Vomiting—Irinotecan—colon cancer	0.000149	0.000843	CcSEcCtD
Sildenafil—Immune system disorder—Methotrexate—colon cancer	0.000148	0.000839	CcSEcCtD
Sildenafil—Dizziness—Fluorouracil—colon cancer	0.000148	0.000839	CcSEcCtD
Sildenafil—Mediastinal disorder—Methotrexate—colon cancer	0.000148	0.000837	CcSEcCtD
Sildenafil—Rash—Irinotecan—colon cancer	0.000147	0.000835	CcSEcCtD
Sildenafil—Dermatitis—Irinotecan—colon cancer	0.000147	0.000835	CcSEcCtD
Sildenafil—Chills—Methotrexate—colon cancer	0.000147	0.000834	CcSEcCtD
Sildenafil—Headache—Irinotecan—colon cancer	0.000146	0.00083	CcSEcCtD
Sildenafil—Hypotension—Capecitabine—colon cancer	0.000146	0.000829	CcSEcCtD
Sildenafil—Alopecia—Methotrexate—colon cancer	0.000145	0.000821	CcSEcCtD
Sildenafil—Mental disorder—Methotrexate—colon cancer	0.000144	0.000814	CcSEcCtD
Sildenafil—Erythema—Methotrexate—colon cancer	0.000143	0.000809	CcSEcCtD
Sildenafil—Malnutrition—Methotrexate—colon cancer	0.000143	0.000809	CcSEcCtD
Sildenafil—Nausea—Vincristine—colon cancer	0.000142	0.000808	CcSEcCtD
Sildenafil—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000142	0.000808	CcSEcCtD
Sildenafil—Vomiting—Fluorouracil—colon cancer	0.000142	0.000807	CcSEcCtD
Sildenafil—Insomnia—Capecitabine—colon cancer	0.000141	0.000802	CcSEcCtD
Sildenafil—Rash—Fluorouracil—colon cancer	0.000141	0.0008	CcSEcCtD
Sildenafil—Dermatitis—Fluorouracil—colon cancer	0.000141	0.000799	CcSEcCtD
Sildenafil—Paraesthesia—Capecitabine—colon cancer	0.00014	0.000796	CcSEcCtD
Sildenafil—Headache—Fluorouracil—colon cancer	0.00014	0.000795	CcSEcCtD
Sildenafil—Dyspnoea—Capecitabine—colon cancer	0.000139	0.000791	CcSEcCtD
Sildenafil—Nausea—Irinotecan—colon cancer	0.000139	0.000787	CcSEcCtD
Sildenafil—Back pain—Methotrexate—colon cancer	0.000138	0.000782	CcSEcCtD
Sildenafil—Dyspepsia—Capecitabine—colon cancer	0.000138	0.000781	CcSEcCtD
Sildenafil—Decreased appetite—Capecitabine—colon cancer	0.000136	0.000771	CcSEcCtD
Sildenafil—Gastrointestinal disorder—Capecitabine—colon cancer	0.000135	0.000766	CcSEcCtD
Sildenafil—Fatigue—Capecitabine—colon cancer	0.000135	0.000765	CcSEcCtD
Sildenafil—Vision blurred—Methotrexate—colon cancer	0.000134	0.000762	CcSEcCtD
Sildenafil—Constipation—Capecitabine—colon cancer	0.000134	0.000758	CcSEcCtD
Sildenafil—Pain—Capecitabine—colon cancer	0.000134	0.000758	CcSEcCtD
Sildenafil—Nausea—Fluorouracil—colon cancer	0.000133	0.000754	CcSEcCtD
Sildenafil—Ill-defined disorder—Methotrexate—colon cancer	0.000132	0.000751	CcSEcCtD
Sildenafil—Anaemia—Methotrexate—colon cancer	0.000132	0.000748	CcSEcCtD
Sildenafil—Feeling abnormal—Capecitabine—colon cancer	0.000129	0.000731	CcSEcCtD
Sildenafil—Malaise—Methotrexate—colon cancer	0.000129	0.000729	CcSEcCtD
Sildenafil—Vertigo—Methotrexate—colon cancer	0.000128	0.000727	CcSEcCtD
Sildenafil—Gastrointestinal pain—Capecitabine—colon cancer	0.000128	0.000725	CcSEcCtD
Sildenafil—Leukopenia—Methotrexate—colon cancer	0.000128	0.000724	CcSEcCtD
Sildenafil—Cough—Methotrexate—colon cancer	0.000124	0.000706	CcSEcCtD
Sildenafil—Urticaria—Capecitabine—colon cancer	0.000124	0.000705	CcSEcCtD
Sildenafil—Abdominal pain—Capecitabine—colon cancer	0.000124	0.000701	CcSEcCtD
Sildenafil—Body temperature increased—Capecitabine—colon cancer	0.000124	0.000701	CcSEcCtD
Sildenafil—Convulsion—Methotrexate—colon cancer	0.000124	0.000701	CcSEcCtD
Sildenafil—Chest pain—Methotrexate—colon cancer	0.000121	0.000689	CcSEcCtD
Sildenafil—Myalgia—Methotrexate—colon cancer	0.000121	0.000689	CcSEcCtD
Sildenafil—Arthralgia—Methotrexate—colon cancer	0.000121	0.000689	CcSEcCtD
Sildenafil—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000121	0.000684	CcSEcCtD
Sildenafil—Discomfort—Methotrexate—colon cancer	0.00012	0.00068	CcSEcCtD
Sildenafil—Infection—Methotrexate—colon cancer	0.000116	0.000656	CcSEcCtD
Sildenafil—Hypersensitivity—Capecitabine—colon cancer	0.000115	0.000653	CcSEcCtD
Sildenafil—Nervous system disorder—Methotrexate—colon cancer	0.000114	0.000647	CcSEcCtD
Sildenafil—Skin disorder—Methotrexate—colon cancer	0.000113	0.000641	CcSEcCtD
Sildenafil—Hyperhidrosis—Methotrexate—colon cancer	0.000113	0.000638	CcSEcCtD
Sildenafil—Asthenia—Capecitabine—colon cancer	0.000112	0.000636	CcSEcCtD
Sildenafil—Anorexia—Methotrexate—colon cancer	0.000111	0.000629	CcSEcCtD
Sildenafil—Pruritus—Capecitabine—colon cancer	0.000111	0.000627	CcSEcCtD
Sildenafil—Hypotension—Methotrexate—colon cancer	0.000109	0.000617	CcSEcCtD
Sildenafil—Diarrhoea—Capecitabine—colon cancer	0.000107	0.000607	CcSEcCtD
Sildenafil—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000106	0.000601	CcSEcCtD
Sildenafil—Insomnia—Methotrexate—colon cancer	0.000105	0.000597	CcSEcCtD
Sildenafil—Paraesthesia—Methotrexate—colon cancer	0.000105	0.000593	CcSEcCtD
Sildenafil—Dyspnoea—Methotrexate—colon cancer	0.000104	0.000589	CcSEcCtD
Sildenafil—Somnolence—Methotrexate—colon cancer	0.000103	0.000587	CcSEcCtD
Sildenafil—Dizziness—Capecitabine—colon cancer	0.000103	0.000586	CcSEcCtD
Sildenafil—Dyspepsia—Methotrexate—colon cancer	0.000102	0.000581	CcSEcCtD
Sildenafil—Decreased appetite—Methotrexate—colon cancer	0.000101	0.000574	CcSEcCtD
Sildenafil—Gastrointestinal disorder—Methotrexate—colon cancer	0.0001	0.00057	CcSEcCtD
Sildenafil—Fatigue—Methotrexate—colon cancer	0.0001	0.000569	CcSEcCtD
Sildenafil—Pain—Methotrexate—colon cancer	9.95e-05	0.000565	CcSEcCtD
Sildenafil—Vomiting—Capecitabine—colon cancer	9.94e-05	0.000564	CcSEcCtD
Sildenafil—Rash—Capecitabine—colon cancer	9.86e-05	0.000559	CcSEcCtD
Sildenafil—Dermatitis—Capecitabine—colon cancer	9.85e-05	0.000559	CcSEcCtD
Sildenafil—Headache—Capecitabine—colon cancer	9.79e-05	0.000556	CcSEcCtD
Sildenafil—Feeling abnormal—Methotrexate—colon cancer	9.59e-05	0.000544	CcSEcCtD
Sildenafil—Gastrointestinal pain—Methotrexate—colon cancer	9.52e-05	0.00054	CcSEcCtD
Sildenafil—Nausea—Capecitabine—colon cancer	9.29e-05	0.000527	CcSEcCtD
Sildenafil—Urticaria—Methotrexate—colon cancer	9.25e-05	0.000524	CcSEcCtD
Sildenafil—Abdominal pain—Methotrexate—colon cancer	9.2e-05	0.000522	CcSEcCtD
Sildenafil—Body temperature increased—Methotrexate—colon cancer	9.2e-05	0.000522	CcSEcCtD
Sildenafil—Hypersensitivity—Methotrexate—colon cancer	8.58e-05	0.000486	CcSEcCtD
Sildenafil—Asthenia—Methotrexate—colon cancer	8.35e-05	0.000474	CcSEcCtD
Sildenafil—Pruritus—Methotrexate—colon cancer	8.23e-05	0.000467	CcSEcCtD
Sildenafil—Diarrhoea—Methotrexate—colon cancer	7.96e-05	0.000452	CcSEcCtD
Sildenafil—Dizziness—Methotrexate—colon cancer	7.7e-05	0.000437	CcSEcCtD
Sildenafil—Vomiting—Methotrexate—colon cancer	7.4e-05	0.00042	CcSEcCtD
Sildenafil—Rash—Methotrexate—colon cancer	7.34e-05	0.000416	CcSEcCtD
Sildenafil—Dermatitis—Methotrexate—colon cancer	7.33e-05	0.000416	CcSEcCtD
Sildenafil—Headache—Methotrexate—colon cancer	7.29e-05	0.000414	CcSEcCtD
Sildenafil—Nausea—Methotrexate—colon cancer	6.91e-05	0.000392	CcSEcCtD
Sildenafil—CYP1A1—Aryl Hydrocarbon Receptor—EP300—colon cancer	2.45e-05	0.00289	CbGpPWpGaD
Sildenafil—CYP1A1—Aryl Hydrocarbon Receptor Pathway—SRC—colon cancer	2.38e-05	0.00281	CbGpPWpGaD
Sildenafil—CYP1A1—Aryl Hydrocarbon Receptor—SRC—colon cancer	2.38e-05	0.00281	CbGpPWpGaD
Sildenafil—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	2.35e-05	0.00277	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—LGR5—colon cancer	2.33e-05	0.00275	CbGpPWpGaD
Sildenafil—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—colon cancer	2.32e-05	0.00274	CbGpPWpGaD
Sildenafil—CYP1A1—Aryl Hydrocarbon Receptor—NRAS—colon cancer	2.29e-05	0.0027	CbGpPWpGaD
Sildenafil—CYP2C19—Arachidonic acid metabolism—PTGS2—colon cancer	2.26e-05	0.00266	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by NGF—FGFR3—colon cancer	2.25e-05	0.00265	CbGpPWpGaD
Sildenafil—ABCC4—Ectoderm Differentiation—CTNNB1—colon cancer	2.21e-05	0.0026	CbGpPWpGaD
Sildenafil—CYP1A1—Aryl Hydrocarbon Receptor—MYC—colon cancer	2.14e-05	0.00252	CbGpPWpGaD
Sildenafil—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—colon cancer	2.13e-05	0.00251	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—CA7—colon cancer	2.12e-05	0.0025	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—CA7—colon cancer	2.12e-05	0.0025	CbGpPWpGaD
Sildenafil—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—colon cancer	2.09e-05	0.00246	CbGpPWpGaD
Sildenafil—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—colon cancer	2.09e-05	0.00246	CbGpPWpGaD
Sildenafil—CYP2C9—Arachidonic acid metabolism—PTGS2—colon cancer	2.06e-05	0.00243	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—CA7—colon cancer	2e-05	0.00236	CbGpPWpGaD
Sildenafil—ABCC5—Transmembrane transport of small molecules—ABCB1—colon cancer	1.99e-05	0.00235	CbGpPWpGaD
Sildenafil—CYP1A1—Aryl Hydrocarbon Receptor—KRAS—colon cancer	1.97e-05	0.00233	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by NGF—BRAF—colon cancer	1.94e-05	0.00229	CbGpPWpGaD
Sildenafil—PDE5A—Hemostasis—EP300—colon cancer	1.89e-05	0.00223	CbGpPWpGaD
Sildenafil—CYP1A1—PPARA activates gene expression—PPARG—colon cancer	1.86e-05	0.0022	CbGpPWpGaD
Sildenafil—PDE5A—Hemostasis—SRC—colon cancer	1.84e-05	0.00216	CbGpPWpGaD
Sildenafil—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—colon cancer	1.82e-05	0.00215	CbGpPWpGaD
Sildenafil—PDE5A—Hemostasis—VEGFA—colon cancer	1.79e-05	0.00211	CbGpPWpGaD
Sildenafil—ABCC4—Ectoderm Differentiation—MYC—colon cancer	1.79e-05	0.00211	CbGpPWpGaD
Sildenafil—ADORA2A—NGF signalling via TRKA from the plasma membrane—CDKN1A—colon cancer	1.78e-05	0.0021	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—CHST5—colon cancer	1.78e-05	0.00209	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—ODC1—colon cancer	1.78e-05	0.00209	CbGpPWpGaD
Sildenafil—PDE5A—Hemostasis—NRAS—colon cancer	1.77e-05	0.00208	CbGpPWpGaD
Sildenafil—ADORA2A—Circadian rythm related genes—EP300—colon cancer	1.73e-05	0.00204	CbGpPWpGaD
Sildenafil—ABCC4—NRF2 pathway—TGFB1—colon cancer	1.7e-05	0.00201	CbGpPWpGaD
Sildenafil—PDE6G—Signaling by Wnt—AKT1—colon cancer	1.7e-05	0.00201	CbGpPWpGaD
Sildenafil—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—colon cancer	1.68e-05	0.00198	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—AXIN2—colon cancer	1.67e-05	0.00197	CbGpPWpGaD
Sildenafil—ADORA2A—NGF signalling via TRKA from the plasma membrane—SRC—colon cancer	1.65e-05	0.00195	CbGpPWpGaD
Sildenafil—PDE5A—Hemostasis—TGFB1—colon cancer	1.64e-05	0.00194	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—CA7—colon cancer	1.64e-05	0.00193	CbGpPWpGaD
Sildenafil—PDE6G—Disease—FGFR3—colon cancer	1.62e-05	0.00191	CbGpPWpGaD
Sildenafil—ADORA2A—NGF signalling via TRKA from the plasma membrane—NRAS—colon cancer	1.59e-05	0.00187	CbGpPWpGaD
Sildenafil—PDE5A—Hemostasis—KRAS—colon cancer	1.52e-05	0.00179	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—CA7—colon cancer	1.51e-05	0.00178	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—CA7—colon cancer	1.49e-05	0.00176	CbGpPWpGaD
Sildenafil—PDE6G—Disease—APC—colon cancer	1.48e-05	0.00175	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by NGF—CASP3—colon cancer	1.46e-05	0.00172	CbGpPWpGaD
Sildenafil—ADORA2A—NGF signalling via TRKA from the plasma membrane—EGFR—colon cancer	1.45e-05	0.00171	CbGpPWpGaD
Sildenafil—PDE5A—Hemostasis—PIK3CA—colon cancer	1.4e-05	0.00165	CbGpPWpGaD
Sildenafil—PDE6G—Disease—BRAF—colon cancer	1.4e-05	0.00165	CbGpPWpGaD
Sildenafil—ABCC4—Transmembrane transport of small molecules—ABCB1—colon cancer	1.38e-05	0.00163	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by NGF—CDKN1A—colon cancer	1.37e-05	0.00162	CbGpPWpGaD
Sildenafil—ABCC4—Platelet activation, signaling and aggregation—SRC—colon cancer	1.37e-05	0.00161	CbGpPWpGaD
Sildenafil—ADORA2A—NGF signalling via TRKA from the plasma membrane—KRAS—colon cancer	1.37e-05	0.00161	CbGpPWpGaD
Sildenafil—PDE5A—Hemostasis—TP53—colon cancer	1.35e-05	0.00159	CbGpPWpGaD
Sildenafil—ABCC4—Platelet activation, signaling and aggregation—VEGFA—colon cancer	1.33e-05	0.00157	CbGpPWpGaD
Sildenafil—PDE5A—Hemostasis—HRAS—colon cancer	1.29e-05	0.00152	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—CHST5—colon cancer	1.29e-05	0.00152	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—ODC1—colon cancer	1.29e-05	0.00152	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—ODC1—colon cancer	1.28e-05	0.00151	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—CHST5—colon cancer	1.28e-05	0.00151	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by NGF—SRC—colon cancer	1.27e-05	0.0015	CbGpPWpGaD
Sildenafil—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—colon cancer	1.26e-05	0.00148	CbGpPWpGaD
Sildenafil—ADORA2A—NGF signalling via TRKA from the plasma membrane—PIK3CA—colon cancer	1.25e-05	0.00148	CbGpPWpGaD
Sildenafil—ADORA2A—Circadian rythm related genes—TP53—colon cancer	1.24e-05	0.00146	CbGpPWpGaD
Sildenafil—ABCC4—Platelet activation, signaling and aggregation—TGFB1—colon cancer	1.22e-05	0.00144	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by NGF—NRAS—colon cancer	1.22e-05	0.00144	CbGpPWpGaD
Sildenafil—CYP1A1—PPARA activates gene expression—EP300—colon cancer	1.22e-05	0.00144	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—CHST5—colon cancer	1.21e-05	0.00143	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—ODC1—colon cancer	1.21e-05	0.00143	CbGpPWpGaD
Sildenafil—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—colon cancer	1.19e-05	0.00141	CbGpPWpGaD
Sildenafil—ADORA2A—NGF signalling via TRKA from the plasma membrane—HRAS—colon cancer	1.16e-05	0.00137	CbGpPWpGaD
Sildenafil—PDE5A—Hemostasis—AKT1—colon cancer	1.14e-05	0.00135	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—FGFR3—colon cancer	1.13e-05	0.00134	CbGpPWpGaD
Sildenafil—PDE6G—Disease—PTGS2—colon cancer	1.13e-05	0.00133	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by NGF—EGFR—colon cancer	1.11e-05	0.00131	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by NGF—KRAS—colon cancer	1.05e-05	0.00124	CbGpPWpGaD
Sildenafil—ABCC4—Platelet activation, signaling and aggregation—PIK3CA—colon cancer	1.04e-05	0.00123	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—APC—colon cancer	1.04e-05	0.00123	CbGpPWpGaD
Sildenafil—ADORA2A—NGF signalling via TRKA from the plasma membrane—AKT1—colon cancer	1.03e-05	0.00121	CbGpPWpGaD
Sildenafil—PDE6G—Disease—CTNNB1—colon cancer	1.01e-05	0.00119	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—CHST5—colon cancer	9.93e-06	0.00117	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—ODC1—colon cancer	9.93e-06	0.00117	CbGpPWpGaD
Sildenafil—PDE6G—Disease—CDKN1A—colon cancer	9.85e-06	0.00116	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—CA7—colon cancer	9.85e-06	0.00116	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—BRAF—colon cancer	9.77e-06	0.00115	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by NGF—PIK3CA—colon cancer	9.65e-06	0.00114	CbGpPWpGaD
Sildenafil—PDE6G—Disease—EP300—colon cancer	9.38e-06	0.00111	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—ABCB1—colon cancer	9.32e-06	0.0011	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—TYMS—colon cancer	9.15e-06	0.00108	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—ODC1—colon cancer	9.13e-06	0.00108	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—CHST5—colon cancer	9.13e-06	0.00108	CbGpPWpGaD
Sildenafil—PDE6G—Disease—SRC—colon cancer	9.12e-06	0.00108	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—ODC1—colon cancer	9.05e-06	0.00107	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—CHST5—colon cancer	9.05e-06	0.00107	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by NGF—HRAS—colon cancer	8.93e-06	0.00105	CbGpPWpGaD
Sildenafil—PDE6G—Disease—NRAS—colon cancer	8.77e-06	0.00103	CbGpPWpGaD
Sildenafil—ABCC5—Disease—FGFR3—colon cancer	8.73e-06	0.00103	CbGpPWpGaD
Sildenafil—ABCC4—Platelet activation, signaling and aggregation—AKT1—colon cancer	8.5e-06	0.001	CbGpPWpGaD
Sildenafil—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—colon cancer	8.23e-06	0.00097	CbGpPWpGaD
Sildenafil—PDE6G—Disease—MYC—colon cancer	8.17e-06	0.000964	CbGpPWpGaD
Sildenafil—PDE6G—Disease—TGFB1—colon cancer	8.15e-06	0.000961	CbGpPWpGaD
Sildenafil—ABCC5—Disease—APC—colon cancer	8.02e-06	0.000946	CbGpPWpGaD
Sildenafil—PDE6G—Disease—EGFR—colon cancer	7.99e-06	0.000943	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by NGF—AKT1—colon cancer	7.89e-06	0.00093	CbGpPWpGaD
Sildenafil—PDE6G—Disease—KRAS—colon cancer	7.55e-06	0.00089	CbGpPWpGaD
Sildenafil—ABCC5—Disease—BRAF—colon cancer	7.54e-06	0.000889	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—CASP3—colon cancer	7.33e-06	0.000864	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—EP300—colon cancer	7.25e-06	0.000855	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—CCND1—colon cancer	7.13e-06	0.000841	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—CTNNB1—colon cancer	7.06e-06	0.000833	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—SRC—colon cancer	7.05e-06	0.000831	CbGpPWpGaD
Sildenafil—PDE6G—Disease—PIK3CA—colon cancer	6.94e-06	0.000818	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—CDKN1A—colon cancer	6.9e-06	0.000814	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—VEGFA—colon cancer	6.87e-06	0.00081	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—NRAS—colon cancer	6.78e-06	0.0008	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—EP300—colon cancer	6.57e-06	0.000774	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—PPARG—colon cancer	6.48e-06	0.000764	CbGpPWpGaD
Sildenafil—PDE6G—Disease—HRAS—colon cancer	6.42e-06	0.000757	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—SRC—colon cancer	6.38e-06	0.000753	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—TGFB1—colon cancer	6.3e-06	0.000743	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—VEGFA—colon cancer	6.22e-06	0.000734	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—NRAS—colon cancer	6.14e-06	0.000725	CbGpPWpGaD
Sildenafil—ABCC5—Disease—PTGS2—colon cancer	6.09e-06	0.000718	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—ODC1—colon cancer	5.97e-06	0.000704	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—CHST5—colon cancer	5.97e-06	0.000704	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—KRAS—colon cancer	5.84e-06	0.000688	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—MYC—colon cancer	5.72e-06	0.000675	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—TGFB1—colon cancer	5.71e-06	0.000673	CbGpPWpGaD
Sildenafil—PDE6G—Disease—AKT1—colon cancer	5.67e-06	0.000668	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—EGFR—colon cancer	5.6e-06	0.00066	CbGpPWpGaD
Sildenafil—ABCC5—Disease—CTNNB1—colon cancer	5.45e-06	0.000643	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—PIK3CA—colon cancer	5.36e-06	0.000633	CbGpPWpGaD
Sildenafil—ABCC5—Disease—CDKN1A—colon cancer	5.32e-06	0.000628	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—KRAS—colon cancer	5.29e-06	0.000624	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—TP53—colon cancer	5.19e-06	0.000612	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—PTGS2—colon cancer	5.1e-06	0.000601	CbGpPWpGaD
Sildenafil—ABCC5—Disease—EP300—colon cancer	5.06e-06	0.000597	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—colon cancer	5.01e-06	0.000591	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—HRAS—colon cancer	4.96e-06	0.000585	CbGpPWpGaD
Sildenafil—ABCC5—Disease—SRC—colon cancer	4.92e-06	0.000581	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—PIK3CA—colon cancer	4.86e-06	0.000573	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—FGFR3—colon cancer	4.83e-06	0.00057	CbGpPWpGaD
Sildenafil—ABCC5—Disease—NRAS—colon cancer	4.74e-06	0.000559	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—TP53—colon cancer	4.7e-06	0.000554	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—ABCB1—colon cancer	4.69e-06	0.000554	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—TYMS—colon cancer	4.61e-06	0.000544	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—HRAS—colon cancer	4.49e-06	0.00053	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—APC—colon cancer	4.44e-06	0.000524	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—NRAS—colon cancer	4.44e-06	0.000524	CbGpPWpGaD
Sildenafil—ABCC5—Disease—MYC—colon cancer	4.41e-06	0.00052	CbGpPWpGaD
Sildenafil—ABCC5—Disease—TGFB1—colon cancer	4.4e-06	0.000519	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—AKT1—colon cancer	4.38e-06	0.000517	CbGpPWpGaD
Sildenafil—ABCC5—Disease—EGFR—colon cancer	4.32e-06	0.000509	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—EP300—colon cancer	4.24e-06	0.0005	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—BRAF—colon cancer	4.17e-06	0.000492	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—colon cancer	4.1e-06	0.000483	CbGpPWpGaD
Sildenafil—ABCC5—Disease—KRAS—colon cancer	4.08e-06	0.000481	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—EGFR—colon cancer	4.04e-06	0.000477	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—AKT1—colon cancer	3.97e-06	0.000468	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	3.94e-06	0.000465	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR downstream signaling—PIK3CA—colon cancer	3.86e-06	0.000456	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—KRAS—colon cancer	3.82e-06	0.000451	CbGpPWpGaD
Sildenafil—ABCC5—Disease—PIK3CA—colon cancer	3.75e-06	0.000442	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—colon cancer	3.74e-06	0.000441	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—PIK3CA—colon cancer	3.51e-06	0.000414	CbGpPWpGaD
Sildenafil—ABCC5—Disease—HRAS—colon cancer	3.47e-06	0.000409	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—ABCB1—colon cancer	3.4e-06	0.000401	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—ABCB1—colon cancer	3.39e-06	0.0004	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—TYMS—colon cancer	3.34e-06	0.000394	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—TYMS—colon cancer	3.33e-06	0.000393	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism of lipids and lipoproteins—EP300—colon cancer	3.28e-06	0.000386	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—PPARG—colon cancer	3.27e-06	0.000385	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—HRAS—colon cancer	3.25e-06	0.000383	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	3.22e-06	0.00038	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—ABCB1—colon cancer	3.21e-06	0.000378	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR downstream signaling—AKT1—colon cancer	3.16e-06	0.000372	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—TYMS—colon cancer	3.15e-06	0.000371	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—PIK3CA—colon cancer	3.14e-06	0.00037	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—CASP3—colon cancer	3.13e-06	0.000369	CbGpPWpGaD
Sildenafil—ABCC5—Disease—AKT1—colon cancer	3.06e-06	0.000361	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—CCND1—colon cancer	3.04e-06	0.000359	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—CTNNB1—colon cancer	3.02e-06	0.000356	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—CDKN1A—colon cancer	2.95e-06	0.000347	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	2.94e-06	0.000347	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—AKT1—colon cancer	2.87e-06	0.000338	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—EP300—colon cancer	2.8e-06	0.000331	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—SRC—colon cancer	2.73e-06	0.000321	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—EP300—colon cancer	2.68e-06	0.000316	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—VEGFA—colon cancer	2.65e-06	0.000313	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—ABCB1—colon cancer	2.62e-06	0.000309	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—NRAS—colon cancer	2.62e-06	0.000309	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—TYMS—colon cancer	2.58e-06	0.000304	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—PTGS2—colon cancer	2.57e-06	0.000303	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—AKT1—colon cancer	2.56e-06	0.000302	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—EP300—colon cancer	2.44e-06	0.000288	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—MYC—colon cancer	2.44e-06	0.000288	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—TGFB1—colon cancer	2.44e-06	0.000287	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	2.42e-06	0.000286	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—ABCB1—colon cancer	2.41e-06	0.000285	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—ABCB1—colon cancer	2.39e-06	0.000282	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—EGFR—colon cancer	2.39e-06	0.000282	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—TYMS—colon cancer	2.37e-06	0.000279	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—PPARG—colon cancer	2.37e-06	0.000279	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—PPARG—colon cancer	2.36e-06	0.000278	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—TYMS—colon cancer	2.35e-06	0.000277	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—KRAS—colon cancer	2.26e-06	0.000266	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—PPARG—colon cancer	2.23e-06	0.000263	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—EP300—colon cancer	2.14e-06	0.000252	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—PIK3CA—colon cancer	2.07e-06	0.000245	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—TP53—colon cancer	2.01e-06	0.000237	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	1.98e-06	0.000234	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—HRAS—colon cancer	1.92e-06	0.000226	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—PTGS2—colon cancer	1.86e-06	0.000219	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—PTGS2—colon cancer	1.86e-06	0.000219	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—PPARG—colon cancer	1.82e-06	0.000215	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	1.81e-06	0.000213	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—PTGS2—colon cancer	1.75e-06	0.000207	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—AKT1—colon cancer	1.69e-06	0.0002	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—PPARG—colon cancer	1.68e-06	0.000198	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—PPARG—colon cancer	1.66e-06	0.000196	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—PIK3CA—colon cancer	1.58e-06	0.000186	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—ABCB1—colon cancer	1.58e-06	0.000186	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—TYMS—colon cancer	1.55e-06	0.000183	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—EP300—colon cancer	1.55e-06	0.000183	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—EP300—colon cancer	1.54e-06	0.000182	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—EP300—colon cancer	1.46e-06	0.000172	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—PTGS2—colon cancer	1.44e-06	0.000169	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—PTGS2—colon cancer	1.32e-06	0.000156	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—PTGS2—colon cancer	1.31e-06	0.000154	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—AKT1—colon cancer	1.29e-06	0.000152	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—EP300—colon cancer	1.19e-06	0.000141	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—PIK3CA—colon cancer	1.14e-06	0.000135	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—PIK3CA—colon cancer	1.14e-06	0.000135	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—EP300—colon cancer	1.1e-06	0.00013	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—PPARG—colon cancer	1.1e-06	0.000129	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—EP300—colon cancer	1.09e-06	0.000128	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—PIK3CA—colon cancer	1.08e-06	0.000127	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—AKT1—colon cancer	9.35e-07	0.00011	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—AKT1—colon cancer	9.33e-07	0.00011	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—PIK3CA—colon cancer	8.83e-07	0.000104	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—AKT1—colon cancer	8.82e-07	0.000104	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—PTGS2—colon cancer	8.63e-07	0.000102	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—PIK3CA—colon cancer	8.12e-07	9.58e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—PIK3CA—colon cancer	8.05e-07	9.5e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—AKT1—colon cancer	7.21e-07	8.51e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—EP300—colon cancer	7.18e-07	8.47e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—AKT1—colon cancer	6.64e-07	7.83e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—AKT1—colon cancer	6.58e-07	7.76e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—PIK3CA—colon cancer	5.31e-07	6.26e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—AKT1—colon cancer	4.34e-07	5.12e-05	CbGpPWpGaD
